EmpaMax M Extended Release Tablet 12.5/1000 mg (Empagliflozin, Metformin)

Adult dose

The dosage of this medication is determined within the range of the maximum recommended daily doses for each ingredient: Empagliflozin 25 mg and extended-release Metformin Hydrochloride not exceeding 2000 mg, taking into consideration each patient's current treatment, efficacy, and tolerability. This medication is taken once daily in the evening with meals to reduce gastrointestinal adverse effects related to Metformin. This medication comes as 10/1000 mg, 25/1000 mg

This medication helps lower blood glucose levels, with the active ingredients being Empagliflozin and Metformin. Rarely, serious metabolic disorders such as lactic acidosis may occur while taking this medication, so immediate consultation with a doctor is necessary if symptoms arise. There is a risk of hypoglycemia when used with other diabetes medications, so caution is needed. Do not use this medication in patients with moderate to severe renal impairment or acute kidney issues. Specific conditions such as severe infections, dehydration, heart failure, pre-and post-surgery, liver dysfunction, or in pregnant women should avoid or use this medication with caution. Regular kidney function tests should be conducted before and during treatment, particularly for elderly or patients with diminished kidney function who may require more frequent testing. As there is a risk of hypoglycemia with this medication, dose adjustment may be necessary when combined with drugs like insulin or sulfonylureas. Urinary tract infections or genital infections may occur during treatment, so rapid treatment is necessary if symptoms arise. Due to the risk of hypotension or dehydration from fluid loss, caution is needed when dehydration symptoms or instability in fluid status are present. This medication may lower vitamin B12 levels, so monitoring vitamin B12 levels is recommended with prolonged use. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid drinking while taking this medication. It is not safe to use this medication in pregnant or potentially pregnant women or breastfeeding women. It is not recommended for children as safety and efficacy have not been established. In case of overdose, lactic acidosis or other serious side effects may occur, so immediate medical attention is required. The tablets should be swallowed whole and not crushed or chewed, and it is normal for the tablet coating to be excreted. During treatment, regular blood tests and physical examinations should be conducted to monitor for adverse reactions, and consultation with medical personnel is required if any unusual symptoms occur.

Serious side effects

Hives, angioedema, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with fever, blisters, skin peeling, mucosal pain in mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory distress with cough + fever, jaundice (yellowing of skin or eyes), profound lethargy, liver issues (jaundice), sudden and severe

Mild side effects

• Nausea
• vomiting
• diarrhea
• abdominal pain
• decreased appetite
• constipation
• altered taste
• itching
• rash
• erythema

Store this medication in a tightly sealed container to prevent exposure to air and moisture. It is best to keep it at room temperature, between 1 and 30 degrees Celsius.

Appearance

Pink oval extended-release film-coated tablet

Package unit

30 tablets/bottle